Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice

被引:0
作者
Hussain, Salam [1 ,2 ,3 ,4 ]
Gale, Chris
Sarma, Shanthi [5 ,6 ]
Smith, Jeremy [7 ]
Bayes, Adam [8 ,9 ]
Loo, Colleen [8 ,9 ,10 ,11 ]
机构
[1] Royal Australian & New Zealand Coll Psychiatrists, Sect Electroconvuls Therapy, Melbourne, Vic, Australia
[2] Royal Australian & New Zealand Coll Psychiatrists, Neurostimulat Binatl Comm Chair, Melbourne, Vic, Australia
[3] Univ Western Australia, Fac Hlth & Med Sci, Sch Psychiat, Perth, WA, Australia
[4] Sir Charles Gairdner Hosp, Mental Hlth Serv, Perth, WA, Australia
[5] Gold Coast Hosp & Hlth Serv, Gold Coast, Qld, Australia
[6] Bond Univ, Gold Coast, Qld, Australia
[7] Southern Inst Neuropsychiat & Aged Psychiat SINAPS, Older Persons Mental Hlth Serv, Hobart, Tas, Australia
[8] Univ New South Wales, Discipline Psychiat, Sydney, NSW, Australia
[9] Black Dog Inst, Randwick, NSW, Australia
[10] George Inst Global Hlth, Barangaroo, NSW, Australia
[11] Ramsay Clin Northside, St Leonards, NSW, Australia
关键词
Guidelines; ketamine; psychiatric disorders; professional practice; depression; TREATMENT-RESISTANT DEPRESSION; ELECTROCONVULSIVE-THERAPY; BIPOLAR DEPRESSION; INTRAVENOUS KETAMINE; RACEMIC KETAMINE; DOUBLE-BLIND; EFFICACY; ANTIDEPRESSANT; DISORDER; SINGLE;
D O I
10.1177/00048674251333577
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Professional practice guidelines for the use of ketamine in psychiatric practice have been developed by the Royal Australian and New Zealand College of Psychiatrists to provide guidance on the use of ketamine in clinical practice in Australia and Aotearoa New Zealand, based on scientific evidence and supplemented by expert clinical consensus. Articles and information were sourced from existing guidelines and published literature. The findings were then formulated into consensus-based recommendations and guidance by the authors. The guidelines were subjected to rigorous successive consultation within the Royal Australian and New Zealand College of Psychiatrists, involving the Section of Electroconvulsive Therapy and Neurostimulation Committee, its broader membership and expert committees. The guidelines are intended for psychiatrists and clinicians engaged in the use of ketamine therapy to facilitate best practice to optimise outcomes for patients. They strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that evidence for ketamine use is continually evolving.
引用
收藏
页数:12
相关论文
共 83 条
  • [31] Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
    Fedgchin, Maggie
    Trivedi, Madhukar
    Daly, Ella J.
    Melkote, Rama
    Lane, Rosanne
    Lim, Pilar
    Vitagliano, Dawn
    Blier, Pierre
    Fava, Maurizio
    Liebowitz, Michael
    Ravindran, Arun
    Gaillard, Raphael
    van den Ameele, Hans
    Preskorn, Sheldon
    Manji, Husseini
    Hough, David
    Drevets, Wayne C.
    Singh, Jaskaran B.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2019, 22 (10) : 616 - 630
  • [32] Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial
    Fernie, Gordon
    Currie, James
    Perrin, Jennifer S.
    Stewart, Caroline A.
    Anderson, Virginica
    Bennett, Daniel M.
    Hay, Steven
    Reid, Ian C.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2017, 210 (06) : 422 - +
  • [33] Fremont Rachel, 2023, Focus (Am Psychiatr Publ), V21, P257, DOI 10.1176/appi.focus.20230006
  • [34] Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression
    George, Duncan
    Galvez, Veronica
    Martin, Donel
    Kumar, Divya
    Leyden, John
    Hadzi-Pavlovic, Dusan
    Harper, Simon
    Brodaty, Henry
    Glue, Paul
    Taylor, Rohan
    Mitchell, Philip B.
    Loo, Colleen K.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (11) : 1199 - 1209
  • [35] Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
    Glue, Paul
    Loo, Colleen
    Fam, Johnson
    Lane, Hsien-Yuan
    Young, Allan H.
    Surman, Peter
    [J]. NATURE MEDICINE, 2024, 30 (07) : 2004 - 2009
  • [36] Influence of formulation and route of administration on ketamine's safety and tolerability: systematic review
    Glue, Paul
    Russell, Bruce
    Medlicott, Natalie J.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 671 - 676
  • [37] Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder
    Grabski, Meryem
    McAndrew, Amy
    Lawn, Will
    Marsh, Beth
    Raymen, Laura
    Stevens, Tobias
    Hardy, Lorna
    Warren, Fiona
    Bloomfield, Michael
    Borissova, Anya
    Maschauer, Emily
    Broomby, Rupert
    Price, Robert
    Coathup, Rachel
    Gilhooly, David
    Palmer, Edward
    Gordon-Williams, Richard
    Hill, Robert
    Harris, Jen
    Mollaahmetoglu, O. Merve
    Curran, H. Valerie
    Brandner, Brigitta
    Lingford-Hughes, Anne
    Morgan, Celia J. A.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (02) : 152 - 162
  • [38] Guthrie AM., 2021, Pediatric Emergency Care, V37
  • [39] The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
    Jawad, Muhammad Youshay
    Qasim, Saleha
    Ni, Menglu
    Guo, Ziji
    Di Vincenzo, Joshua D.
    d'Andrea, Giacomo
    Tabassum, Aniqa
    Mckenzie, Andrea
    Badulescu, Sebastian
    Grande, Iria
    McIntyre, Roger S.
    [J]. BRAIN SCIENCES, 2023, 13 (06)
  • [40] Ketamine in neuropsychiatric disorders: an update
    Johnston, Jenessa N. N.
    Kadriu, Bashkim
    Kraus, Christoph
    Henter, Ioline D. D.
    Zarate, Carlos A. A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2024, 49 (01) : 23 - 40